Hearing loss in individuals with osteogenesis imperfecta in North America: Results from a multicenter study. Issue 4 (26th December 2019)

• Record Type: Journal Article
• Authors: Machol, Keren; Hadley, Trevor D.; Schmidt, Jake; Cuthbertson, David; Traboulsi, Henri; Silva, Rodrigo C.; Citron, Chloe; Khan, Sobiah; Citron, Kate; Carter, Erin; Brookler, Kenneth; Shapiro, Jay R.; Steiner, Robert D.; Byers, Peter H.; Glorieux, Francis H.; Durigova, Michaela; Smith, Peter; Bober, Michael B.; Sutton, Vernon R.; Lee, Brendan H.; Nagamani, Sandesh C. S.; Raggio, Cathleen
• Is Part Of: American journal of medical genetics. Volume 182:Issue 4(2020)
• Page Start: 697
• Page End: 704
• Publication Date: 2019-12-26
• Subjects: hearing loss -- natural history study -- osteogenesis imperfecta -- Type I collagen; Medical genetics -- Periodicals; 616.14205
• DOI: 10.1002/ajmg.a.61464
• Languages: English
• ISSNs: 1552-4825

Abstract

Abstract: Hearing loss (HL) is an extra‐skeletal manifestation of the connective tissue disorder osteogenesis imperfecta (OI). Systematic evaluation of the prevalence and characteristics of HL in COL1A1/COL1A2‐related OI will contribute to a better clinical management of individuals with OI. We collected and analyzed pure‐tone audiometry data from 312 individuals with OI who were enrolled in the Linked Clinical Research Centers and the Brittle Bone Disorders Consortium. The prevalence, type, and severity of HL in COL1A1/COL1A2‐related OI are reported. We show that the prevalence of HL in OI is 28% and increased with age in Type I OI but not in Types III and IV. Individuals with OI Types III and IV are at a higher risk to develop HL in the first decade of life when compared to OI Type I. We also show that the prevalence of SNHL is higher in females with OI compared to males. This study reveals new insights regarding prevalence of HL in OI including a lower general prevalence of HL in COL1A1/COL1A2‐related OI than previously reported (28.3 vs. 65%) and high prevalence of SNHL in females. Our data support the need in early routine hearing evaluation in all types of OI that can be adjusted to the severity of the skeletal disease.